[VRDN] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 27.01%
YoY- 33.22%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 476 944 2,182 4,784 1,192 1,631 718 -23.91%
PBT -10,317 -9,011 -8,714 -4,661 -6,386 -5,834 -7,312 25.72%
Tax 289 362 361 167 77 113 102 99.85%
NP -10,317 -9,011 -8,714 -4,661 -6,386 -5,834 -7,312 25.72%
Tax Rate - - - - - - - -
Total Cost 10,793 9,955 10,896 9,445 7,578 7,465 8,030 21.72%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -2,167.44 -954.56 -399.36 -97.43 -535.74 -357.69 -1,018.38 65.23%
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -5.02 -4.40 -4.31 -2.64 -4.30 -4.06 -5.12 -1.30%
EPS Diluted -5.02 -4.40 -4.31 -2.64 -4.30 -4.06 -5.12 -1.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.